Company profile for Engitix Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Our mission is to identify novel drug targets and effective therapeutics for fibrosis and solid tumours by testing cells in their natural microenvironment using our pioneering human extracellular matrix platform. We are developing a portfolio of programmes in fibrosis and solid tumours using our proprietary human extracellular matrix (ECM)-based discovery platform. The use of physiologically realistic human in vitro models is ...
Our mission is to identify novel drug targets and effective therapeutics for fibrosis and solid tumours by testing cells in their natural microenvironment using our pioneering human extracellular matrix platform. We are developing a portfolio of programmes in fibrosis and solid tumours using our proprietary human extracellular matrix (ECM)-based discovery platform. The use of physiologically realistic human in vitro models is transforming our ability to identify new targets, determine mechanisms of action, and increase the success rate of therapeutic candidates.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
United Kingdom
Address
Address
Royal Free Hospital (1st Floor), Rowland Hill Street, London NW3 2PF
Telephone
Telephone
+44 (0)20 7435 3343
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Clinical Outsourcing

Clinical Outsourcing

Not Confirmed

envelop Contact Supplier

Clinical Outsourcing

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.pharmiweb.com/press-release/2026-01-08/engitix-announces-25-million-series-a-extension-financing-by-existing-investor-mike-platt-to-advance-ecm-targeted-therapeutics-in-solid-tumors-and-fi

PHARMIWEB
08 Jan 2026

https://www.globenewswire.com/news-release/2024/06/25/2903516/0/en/Engitix-appoints-two-additional-international-biotech-industry-leaders-as-Scientific-Advisors.html

GLOBENEWSWIRE
25 Jun 2024

https://www.globenewswire.com/news-release/2024/05/21/2885332/0/en/Engitix-Announces-Appointment-of-Matthew-Edwards-Ph-D-as-SVP-Discovery-and-Emma-Huang-Ph-D-as-VP-Data-Sciences.html

GLOBENEWSWIRE
21 May 2024

https://www.globenewswire.com//news-release/2023/09/05/2737129/0/en/Engitix-Announces-Appointment-of-Christopher-Stevenson-Ph-D-as-Chief-Scientific-Officer.html

GLOBENEWSWIRE
05 Sep 2023

https://www.globenewswire.com/news-release/2023/05/09/2664092/0/en/Engitix-Announces-Appointment-of-Sonia-Quaratino-M-D-Ph-D-as-Independent-Non-executive-Director.html

GLOBENEWSWIRE
09 May 2023

https://www.businesswire.com/news/home/20220118005985/en

BUSINESSWIRE
18 Jan 2022

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty